Lyndra Therapeutics’ Post

View organization page for Lyndra Therapeutics, graphic

7,991 followers

Our Chief Technology Officer Kyle Haraldsen shared insights with European Pharmaceutical Review on emerging trends in drug delivery, including Lyndra’s work developing long-acting oral therapies. “…We need to make sure we’re creating things that patients actually want – being truly patient-centric... This is why we’re focused on developing long-acting oral medicines at Lyndra. It’s a drug delivery method that patients know and like, and the potential benefits of long-acting medicines are clear: they can reduce patient and caregiver burden, increase medication adherence and, in turn, produce better patient outcomes.” Read the full interview here: https://lnkd.in/ea6xT-UY #drugdelivery #innovation #biotech

To view or add a comment, sign in

Explore topics